Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Researchers developed a method to grow hair follicles using special beads that could help with hair loss treatment.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Antimicrobial lotion reduces inflammation and increases hair density in hair loss patients.

Improved Finasteride delivery for hair loss treatment.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Men with testicular cancer were less likely to experience baldness and severe acne.

Hair loss in women not always linked to increased oil production; other factors may be involved.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Left-handed men experience more sexual side effects from finasteride treatment.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Finasteride safely treats hair loss without harming hormones or reproduction, but may slightly reduce sexual function.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Mutation in hairless gene may increase hair loss risk.

Certain nutrients can help keep skin healthy as we age.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Adding platelet-rich plasma improves hair density and thickness in androgenetic alopecia.